DE NOVO MYELODYSPLASTIC SYNDROME
Clinical trials for DE NOVO MYELODYSPLASTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new DE NOVO MYELODYSPLASTIC SYNDROME trials appear
Sign up with your email to follow new studies for DE NOVO MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost remission in hard-to-treat leukemia
Disease control Recruiting nowThis study tests a mix of five drugs (fludarabine, cytarabine, filgrastim-sndz, gemtuzumab ozogamicin, and idarubicin) in 270 adults with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome that have specific genetic changes. The goal is to see how well t…
Matched conditions: DE NOVO MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Horse blood protein combo aims to boost blood counts in bone marrow failure
Disease control Recruiting nowThis study tests a mix of medicines—including a protein from horse blood—to treat aplastic anemia and low-risk myelodysplastic syndrome (MDS). These conditions cause dangerously low blood cell counts. The treatment aims to kill overactive immune cells and stimulate white blood ce…
Matched conditions: DE NOVO MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC